{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:23:16Z","timestamp":1793622196542,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of the Jiangsu Higher Education Institutions of China","award":["No. 23KJA320003"],"award-info":[{"award-number":["No. 23KJA320003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01358-5","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:05:32Z","timestamp":1772751932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["NDUFA4L2 regulates the progression and chemotherapy sensitivity of HNSCC by inhibiting PANoptosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Jing-Jing","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"1358_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim. 6, 92 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1358_CR2","doi-asserted-by":"publisher","unstructured":"Barsouk, A., Aluru, J. S., Rawla, P., Saginala, K. & Barsouk, A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med. Sci. 11, https:\/\/doi.org\/10.3390\/medsci11020042 (2023).","DOI":"10.3390\/medsci11020042"},{"key":"1358_CR3","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cisplatin resistance. Oncogene 31, 1869\u20131883 (2012).","journal-title":"Oncogene"},{"key":"1358_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct. Target. Ther. 7, 286 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1358_CR5","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1002\/anie.202010281","volume":"60","author":"D Wu","year":"2021","unstructured":"Wu, D., Wang, S., Yu, G. & Chen, X. Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew. Chem. Int Ed. Engl. 60, 8018\u20138034 (2021).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"1358_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui, S., Herold, M. J. & Strasser, A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat. Rev. Mol. Cell Biol. 21, 678\u2013695 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1358_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","volume":"9","author":"RKS Malireddi","year":"2019","unstructured":"Malireddi, R. K. S., Kesavardhana, S. & Kanneganti, T. ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front. Cell. Infect. Microbiol. 9, 406 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1358_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597, 415\u2013419 (2021).","journal-title":"Nature"},{"key":"1358_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2148-12-140","volume":"12","author":"JA Cridland","year":"2012","unstructured":"Cridland, J. A. et al. The mammalian PYHIN gene family: phylogeny, evolution and expression. BMC Evol. Biol. 12, 140 (2012).","journal-title":"BMC Evol. Biol."},{"key":"1358_CR10","doi-asserted-by":"publisher","unstructured":"Zhang, M., Zhang, L., Miao, T. & Hu, X. Characterization of PANoptosis-related expression pattern, prognosis and tumor microenvironment in head and neck squamous cell carcinoma. Discov. Oncol. https:\/\/doi.org\/10.1007\/s12672-025-04328-8 (2025).","DOI":"10.1007\/s12672-025-04328-8"},{"key":"1358_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60441-8","volume":"14","author":"P Yang","year":"2024","unstructured":"Yang, P. et al. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma. Sci. Rep. 14, 9824 (2024).","journal-title":"Sci. Rep."},{"key":"1358_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2011.10.008","volume":"14","author":"D Tello","year":"2011","unstructured":"Tello, D. et al. Induction of the mitochondrial NDUFA4L2 protein by HIF-1alpha decreases oxygen consumption by inhibiting Complex I activity. Cell Metab. 14, 768\u2013779 (2011).","journal-title":"Cell Metab."},{"key":"1358_CR13","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1158\/1078-0432.CCR-15-1987","volume":"22","author":"RK Lai","year":"2016","unstructured":"Lai, R. K. et al. NDUFA4L2 fine-tunes oxidative stress in hepatocellular carcinoma. Clin. Cancer Res. 22, 3105\u20133117 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1358_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10616-023-00590-2","volume":"75","author":"N Ye","year":"2023","unstructured":"Ye, N. et al. Hypoxia-induced the upregulation of NDUFA4L2 promoted colon adenocarcinoma progression through ROS-mediated PI3K\/AKT pathway. Cytotechnology 75, 461\u2013472 (2023).","journal-title":"Cytotechnology"},{"key":"1358_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/1759-7714.12984","volume":"10","author":"L Meng","year":"2019","unstructured":"Meng, L., Yang, X., Xie, X. & Wang, M. Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress. Thorac. Cancer 10, 676\u2013685 (2019).","journal-title":"Thorac. Cancer"},{"key":"1358_CR16","doi-asserted-by":"publisher","first-page":"17527428","DOI":"10.1177\/17588359211027836","volume":"13","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y. et al. NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer. Ther. Adv. Med. Oncol. 13, 17527428 (2021).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"1358_CR17","doi-asserted-by":"publisher","unstructured":"Wang, D., Zhang, P., Liu, Z., Xing\u2019, Y. & Xiao, Y. NXPH4 promotes gemcitabine resistance in bladder cancer by enhancing reactive oxygen species and glycolysis activation through modulating NDUFA4L2. Cancers. 14, https:\/\/doi.org\/10.3390\/cancers14153782 (2022).","DOI":"10.3390\/cancers14153782"},{"key":"1358_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/cas.15648","volume":"114","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma. Cancer Sci. 114, 793\u2013805 (2023).","journal-title":"Cancer Sci."},{"key":"1358_CR19","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.oraloncology.2021.105451","volume":"121","author":"A Chamoli","year":"2021","unstructured":"Chamoli, A. et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral. Oncol. 121, 105451 (2021).","journal-title":"Oral. Oncol."},{"key":"1358_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519\u2013530 (1927).","journal-title":"J. Gen. Physiol."},{"key":"1358_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"1358_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02950-5","volume":"9","author":"F Li","year":"2018","unstructured":"Li, F. et al. Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis. Nat. Commun. 9, 508 (2018).","journal-title":"Nat. Commun."},{"key":"1358_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0562-y","volume":"15","author":"S Faes","year":"2016","unstructured":"Faes, S. et al. Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors. Mol. Cancer 15, 78 (2016).","journal-title":"Mol. Cancer"},{"key":"1358_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0845-7","volume":"19","author":"Y Lin","year":"2019","unstructured":"Lin, Y. et al. Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells. Cancer Cell Int. 19, 129 (2019).","journal-title":"Cancer Cell Int."},{"key":"1358_CR25","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20201302","author":"S Zong","year":"2020","unstructured":"Zong, S., Dai, W., Fang, W., Guo, X. & Wang, K. SIK2 promotes cisplatin resistance induced by aerobic glycolysis in breast cancer cells through PI3K\/AKT\/mTOR signaling pathway. Biosci. Rep. https:\/\/doi.org\/10.1042\/BSR20201302 (2020).","journal-title":"Biosci. Rep."},{"key":"1358_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-021-01959-x","volume":"40","author":"Y Tan","year":"2021","unstructured":"Tan, Y. et al. Pyroptosis: a new paradigm of cell death for fighting against cancer. J. Exp. Clin. Cancer Res. 40, 153 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1358_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj3150021","volume":"315","author":"EA Slee","year":"1996","unstructured":"Slee, E. A. et al. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315, 21\u201324 (1996).","journal-title":"Biochem. J."},{"key":"1358_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41401-020-0434-2","volume":"42","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure. Acta Pharmacol. Sin. 42, 68\u201376 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"1358_CR29","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao, L. & Mu, W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol. Res. 163, 105297 (2021).","journal-title":"Pharmacol. Res."},{"key":"1358_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"1358_CR31","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s11427-017-9142-2","volume":"60","author":"X Yu","year":"2017","unstructured":"Yu, X. & He, S. GSDME as an executioner of chemotherapy-induced cell death. Sci. China Life Sci. 60, 1291\u20131294 (2017).","journal-title":"Sci. China Life Sci."},{"key":"1358_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41556-025-01635-8","volume":"27","author":"Z Zong","year":"2025","unstructured":"Zong, Z., Ren, J., Yang, B., Zhang, L. & Zhou, F. Emerging roles of lysine lactyltransferases and lactylation. Nat. Cell Biol. 27, 563\u2013574 (2025).","journal-title":"Nat. Cell Biol."},{"key":"1358_CR33","doi-asserted-by":"publisher","first-page":"114778","DOI":"10.1016\/j.biopha.2023.114778","volume":"163","author":"H Hu","year":"2023","unstructured":"Hu, H. et al. New advances into cisplatin resistance in head and neck squamous carcinoma: mechanisms and therapeutic aspects. Biomed. Pharmacother. 163, 114778 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"1358_CR34","doi-asserted-by":"publisher","first-page":"e25462","DOI":"10.1016\/j.heliyon.2024.e25462","volume":"10","author":"Q Mei","year":"2024","unstructured":"Mei, Q. et al. Elevated of NDUFA4L2 expression in colon adenocarcinoma is correlated with an unfavorable prognosis and increased immune cell infiltration. Heliyon 10, e25462 (2024).","journal-title":"Heliyon"},{"key":"1358_CR35","doi-asserted-by":"publisher","first-page":"E251","DOI":"10.1111\/ans.13617","volume":"87","author":"Y Lv","year":"2017","unstructured":"Lv, Y. et al. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer. ANZ J. Surg. 87, E251\u2013E255 (2017).","journal-title":"ANZ J. Surg."},{"key":"1358_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84353-9","volume":"15","author":"H He","year":"2025","unstructured":"He, H. et al. Nucleotide metabolism-associated drug resistance gene NDUFA4L2 promotes colon cancer progression and 5-FU resistance. Sci. Rep. 15, 570 (2025).","journal-title":"Sci. Rep."},{"key":"1358_CR37","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00405-018-5134-x","volume":"275","author":"L Li","year":"2018","unstructured":"Li, L. et al. The identification of induction chemo-sensitivity genes of laryngeal squamous cell carcinoma and their clinical utilization. Eur. Arch. Otorhinolaryngol. 275, 2773\u20132781 (2018).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"1358_CR38","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad, R. M. et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 35, S78\u2013S103 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"1358_CR39","doi-asserted-by":"publisher","first-page":"1120034","DOI":"10.3389\/fimmu.2023.1120034","volume":"14","author":"P Zhu","year":"2023","unstructured":"Zhu, P. et al. Advances in mechanism and regulation of PANoptosis: prospects in disease treatment. Front. Immunol. 14, 1120034 (2023).","journal-title":"Front. Immunol."},{"key":"1358_CR40","doi-asserted-by":"publisher","first-page":"11163","DOI":"10.18632\/aging.103528","volume":"12","author":"RKS Malireddi","year":"2020","unstructured":"Malireddi, R. K. S., Tweedell, R. E. & Kanneganti, T. PANoptosis components, regulation, and implications. Aging 12, 11163\u201311164 (2020).","journal-title":"Aging"},{"key":"1358_CR41","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/cdd.2013.37","volume":"20","author":"V Sagulenko","year":"2013","unstructured":"Sagulenko, V. et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ. 20, 1149\u20131160 (2013).","journal-title":"Cell Death Differ."},{"key":"1358_CR42","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.7150\/thno.102995","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma. Theranostics 14, 6798\u20136817 (2024).","journal-title":"Theranostics"},{"key":"1358_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03104-6","volume":"11","author":"W Gao","year":"2020","unstructured":"Gao, W. et al. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis. Cell Death Dis. 11, 919 (2020).","journal-title":"Cell Death Dis."},{"key":"1358_CR44","doi-asserted-by":"publisher","first-page":"15941","DOI":"10.1002\/jcp.28253","volume":"234","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1\/TEAD1\/GLUT1 pathway. J. Cell. Physiol. 234, 15941\u201315950 (2019).","journal-title":"J. Cell. Physiol."},{"key":"1358_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2007.07.021","volume":"257","author":"S Rastogi","year":"2007","unstructured":"Rastogi, S., Banerjee, S., Chellappan, S. & Simon, G. R. Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines. Cancer Lett. 257, 244\u2013251 (2007).","journal-title":"Cancer Lett."},{"key":"1358_CR46","doi-asserted-by":"publisher","first-page":"12759","DOI":"10.1074\/jbc.M212392200","volume":"278","author":"C Munoz-Pinedo","year":"2003","unstructured":"Munoz-Pinedo, C., Ruiz-Ruiz, C., Ruiz De Almodovar, C., Palacios, C. & Lopez-Rivas, A. Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. J. Biol. Chem. 278, 12759\u201312768 (2003).","journal-title":"J. Biol. Chem."},{"key":"1358_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02047-9","volume":"23","author":"F Sun","year":"2025","unstructured":"Sun, F. et al. Impact of glycolysis enzymes and metabolites in regulating DNA damage repair in tumorigenesis and therapy. Cell Commun. Signal. 23, 44 (2025).","journal-title":"Cell Commun. Signal."},{"key":"1358_CR48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","journal-title":"Nature"},{"key":"1358_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","volume":"28","author":"J Cong","year":"2018","unstructured":"Cong, J. et al. Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression. Cell Metab. 28, 243\u2013255 (2018).","journal-title":"Cell Metab."},{"key":"1358_CR50","doi-asserted-by":"publisher","first-page":"i8602","DOI":"10.1126\/sciadv.abi8602","volume":"7","author":"JT Noe","year":"2021","unstructured":"Noe, J. T. et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci. Adv. 7, i8602 (2021).","journal-title":"Sci. Adv."},{"key":"1358_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"1358_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00824-9","volume":"13","author":"S Liu","year":"2025","unstructured":"Liu, S. et al. Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications. Biomark. Res. 13, 110 (2025).","journal-title":"Biomark. Res."},{"key":"1358_CR53","doi-asserted-by":"publisher","first-page":"qzaf072","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genom. Proteom. Bioinforma. 23, qzaf072 (2025).","journal-title":"Genom. Proteom. Bioinforma."},{"key":"1358_CR54","unstructured":"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic. Acids. Res. 53, D30-D44 (2025)."},{"key":"1358_CR55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley, D. et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 54, 1192\u20131201 (2022).","journal-title":"Nat. Genet."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01358-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01358-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01358-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T19:01:29Z","timestamp":1776366089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01358-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01358-5","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}